Tenet Healthcare (THC) PT Raised to $100 at Raymond James
- Wall Street closes rollercoaster week sharply lower
- Invesco (IVZ) Reportedly in Talks to Merge With State Street's (STT) Asset Management Business, Citi Sees More Cons than Pros
- FDA Votes "No" on Pfizer (PFE) Booster for 16+ Age Group, 2 Yes 16 No
- Jefferies Raises Price Targets on Alphabet (GOOGL) and Facebook (FB) as They Are Still Inexpensive Relative to Growth, Reiterates Snap (SNAP) as a Best Growth Idea
- Tesla (TSLA) Could Deliver 900K EV Units This Year and 1.3M in 2022 - Wedbush
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Raymond James analyst John Ransom raised the price target on Tenet Healthcare (NYSE: THC) to $100.00 (from $90.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- South32 Limited (S32:AU) (SHTLF) PT Raised to AUD4.10 at Macquarie
- Sandfire Resources NL (SFR:AU) PT Raised to AUD10.20 at Macquarie
- Smartgroup Corp. Ltd. (SIQ:AU) PT Raised to AUD7.90 at Macquarie
Create E-mail Alert Related CategoriesAnalyst PT Change
Related EntitiesRaymond James
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!